Pharma & Biotech

The proposed multi-billion euro acquisition of CureVac by BioNTech enters its final phase with two crucial November deadlines approaching. Shareholders...

Shares of Viking Therapeutics experienced significant upward momentum this week, fueled by renewed takeover speculation and a positive analyst update....

The Dow Jones Industrial Average surged to an unprecedented milestone on Wednesday, closing above 47,974 points for the first time...

The financial markets occasionally present puzzling scenarios where corporate achievements clash with investor behavior. Bionxt Solutions currently finds itself in...

Today marks a pivotal juncture for Applied Therapeutics as the biopharmaceutical firm prepares to release its third-quarter 2025 financial results....

After a prolonged period of disappointing its shareholders, the pioneering coronavirus vaccine developer is showing signs of a potential resurgence....

The investment landscape for Intellia Therapeutics has grown increasingly turbulent. A recent fatality within one of the company's clinical trials...

PDS Biotechnology Corp witnessed a sharp decline in its share price following the announcement of a new financing arrangement designed...

IQVIA Holdings Inc. has delivered a powerful performance in its latest quarterly report, exceeding market projections and reinforcing its strategic...

Investors in the telemedicine platform Hims & Hers are facing a complex investment landscape. While the company continues to demonstrate...